An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life

CompletedOBSERVATIONAL
Enrollment

147

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Psoriasis Vulgaris
Trial Locations (12)

10155

Skin Specialty Dermatology, New York

23233

West End Dermatology, Richmond

33134

Dermatology Associates and Research, Coral Gables

33756

Academic Alliance Dermatology, Clearwater

40701

Melissa Knuckles Dermatology, Corbin

48088

Grekin Skin Institute, Warren

77598

Center for Clinical Studies, Webster

85032

Alliance Dermatology and Mohs Center, Phoenix

89074

Bettencourt Skin Center, Henderson

89128

Las Vegas Skin and Cancer Clinic, Las Vegas

94538

Center for Dermatology Clinical Research, Fremont

08520

Psoriasis Treatment Center of Central NJ, East Windsor

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LEO Pharma

INDUSTRY